Apoptosis Modulation as a Target for Systemic Sclerosis Treatment
Author Information
Author(s): Stéphane Chabaud, Véronique J. Moulin
Primary Institution: Centre LOEX de l'Université Laval, Québec City, Canada
Hypothesis
The study aims to gather new findings in apoptosis related to systemic sclerosis (SSc) and identify new therapeutic targets.
Conclusion
Apoptosis plays a crucial role in the emergence and maintenance of systemic sclerosis, and understanding its mechanisms could lead to new therapies.
Supporting Evidence
- Apoptosis is involved in immune system response and vascular damage in systemic sclerosis.
- Fibroblasts in systemic sclerosis are more resistant to apoptosis, contributing to fibrosis.
- Understanding apoptosis mechanisms could lead to targeted therapies for systemic sclerosis.
Takeaway
This study looks at how a process called apoptosis, which is how cells die, is important in a disease called systemic sclerosis, and how understanding this could help find new treatments.
Methodology
The paper reviews various mechanisms of apoptosis and their relation to systemic sclerosis, highlighting findings from animal models and human studies.
Limitations
The study does not provide exhaustive descriptions of all apoptotic pathways and focuses mainly on major ones.
Participant Demographics
The disease affects more African American women than Caucasian men, with a higher mortality rate in women over the last twenty years.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website